Ernexa Therapeutics, Inc. (ERNA)
1.31
+0.16
(+13.91%)
USD |
NASDAQ |
Dec 04, 16:00
1.29
-0.02
(-1.53%)
After-Hours: 20:00
Ernexa Therapeutics Market Cap: 9.643M for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 137.35M |
| Palatin Technologies, Inc. | 20.44M |
| Theriva Biologics, Inc. | 8.152M |
| Oragenics, Inc. | 0.7008M |
| NanoViricides, Inc. | 21.96M |
Market Cap Related Metrics
| PS Ratio | 38694.78 |
| Price to Book Value | 2.702 |
| Price | 1.31 |
| Earnings Yield | -198.1% |